Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 29
2023 4
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Neonatal disorders and lower respiratory infections remained the leading level 3 CMNN causes globally in 2023, although both showed notable rate decreases from 2010, declining by 16.5% (10.6-22.0) and 24.8% (7.4-36.7), respectively. Injury-related age-standardised DALY rat …
Neonatal disorders and lower respiratory infections remained the leading level 3 CMNN causes globally in 2023, although both showed notable …
Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Breast Cancer Collaborators. GBD 2023 Breast Cancer Collaborators. Lancet Oncol. 2026 Mar;27(3):302-326. doi: 10.1016/S1470-2045(25)00730-2. Lancet Oncol. 2026. PMID: 41785894
The highest ASIR was in the high-income group (75.7 per 100 000 [67.1 to 84.0]), and the lowest ASMR was in the upper-middle-income group (11.2 per 100 000 [10.2 to 12.3]). Between 1990 and 2023, the ASIR in the low-income group increased by 147.2% (38.1 to 271.7), compare …
The highest ASIR was in the high-income group (75.7 per 100 000 [67.1 to 84.0]), and the lowest ASMR was in the upper-middle-income group (1 …
Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 TB HIV Collaborators. GBD 2023 TB HIV Collaborators. Lancet Infect Dis. 2026 Jul 1:S1473-3099(26)00295-1. doi: 10.1016/S1473-3099(26)00295-1. Online ahead of print. Lancet Infect Dis. 2026. PMID: 42385762
FINDINGS: In 2023, there were an estimated 9.11 million (95% uncertainty interval 8.04-10.3) incident cases of all-form TB, 1.22 million (0.98-1.49) deaths, and 54.6 million (43.8-65.5) DALYs globally. ...
FINDINGS: In 2023, there were an estimated 9.11 million (95% uncertainty interval 8.04-10.3) incident cases of all-form TB, 1.22 mill …
Potential Antiviral Action of Alkaloids.
Abookleesh FL, Al-Anzi BS, Ullah A. Abookleesh FL, et al. Molecules. 2022 Jan 28;27(3):903. doi: 10.3390/molecules27030903. Molecules. 2022. PMID: 35164173 Free PMC article. Review.
The purpose of this review was to summarize the evidence supporting the efficacy of the antiviral activity of plant alkaloids at half-maximum effective concentration (EC(50)) or half-maximum inhibitory concentration (IC(50)) below 10 muM and describe the molecular sites mo …
The purpose of this review was to summarize the evidence supporting the efficacy of the antiviral activity of plant alkaloids at half-maximu …
Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Lancet Infect Dis. 2026 Apr;26(4):343-361. doi: 10.1016/S1473-3099(25)00689-9. Epub 2025 Dec 15. Lancet Infect Dis. 2026. PMID: 41412141
LRI mortality in children younger than 5 years fell by 33.4% (10.4-47.4) since 2010, with a global mortality rate of 94.8 (75.6-116.4) per 100 000 person-years in 2023. ...Streptococcus pneumoniae continued to account for the largest number of LRI deaths globally (634 000 …
LRI mortality in children younger than 5 years fell by 33.4% (10.4-47.4) since 2010, with a global mortality rate of 94.8 (75.6-116.4 …
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Demographics Collaborators. GBD 2023 Demographics Collaborators. Lancet. 2025 Oct 18;406(10513):1731-1810. doi: 10.1016/S0140-6736(25)01330-3. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092927 Free PMC article.
Finally, the world experienced a period of post-pandemic recovery in 2022 and 2023, wherein life expectancy generally returned to pre-pandemic (2019) levels in 2023 (76.3 [76.0-76.6] years for females and 71.5 [71.2-71.8] years for males). 194 (95.1%) of 204 countries and …
Finally, the world experienced a period of post-pandemic recovery in 2022 and 2023, wherein life expectancy generally returned to pre …
Biogenic Selenium Nanoparticles and Their Anticancer Effects Pertaining to Probiotic Bacteria-A Review.
Ullah A, Mu J, Wang F, Chan MWH, Yin X, Liao Y, Mirani ZA, Sebt-E-Hassan S, Aslam S, Naveed M, Khan MN, Khatoon Z, Kazmi MR. Ullah A, et al. Antioxidants (Basel). 2022 Sep 27;11(10):1916. doi: 10.3390/antiox11101916. Antioxidants (Basel). 2022. PMID: 36290639 Free PMC article. Review.
However, biogenic synthesis (by microorganisms) is an eco-friendly and economical technique that is non-toxic to human and animal health. The mechanism for biogenic SeNPs from microorganisms is still not well understood. ...The research revealed that biogenic SeNPs are con …
However, biogenic synthesis (by microorganisms) is an eco-friendly and economical technique that is non-toxic to human and animal hea …
Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
Aziz S, Almajhdi FN, Waqas M, Ullah I, Salim MA, Khan NA, Ali A. Aziz S, et al. Front Immunol. 2022 Oct 13;13:1004804. doi: 10.3389/fimmu.2022.1004804. eCollection 2022. Front Immunol. 2022. PMID: 36311762 Free PMC article.
Herein, we searched a publicly accessible database (Virus Pathogen Database and Analysis Resource) for MPXV immune epitopes from various antigens. We prioritized a group of epitopes (10 CD8+ T cells and four B-cell epitopes) using a computer-aided technique based on desira …
Herein, we searched a publicly accessible database (Virus Pathogen Database and Analysis Resource) for MPXV immune epitopes from various ant …
A global review of racial, ethnic and socio-economic disparities in multisystem inflammatory syndrome in children related to COVID-19.
Asghar Z, Sharaf K, Butt FA, Shaikh OA, Shekha M, Waris A, Ullah I, Nashwan AJ. Asghar Z, et al. Front Public Health. 2022 Oct 20;10:996311. doi: 10.3389/fpubh.2022.996311. eCollection 2022. Front Public Health. 2022. PMID: 36339223 Free PMC article. Review.
Initially, children were thought to be spared but reports of a new phenomenon manifesting as Kawasaki-like disease, toxic shock syndrome, and multi-system inflammatory syndrome, which developed after a few weeks of severe COVID-19 infection, emerged in the pediatric popula …
Initially, children were thought to be spared but reports of a new phenomenon manifesting as Kawasaki-like disease, toxic shock syndr …
Antibacterial and in vivo toxicological studies of Bi2O3/CuO/GO nanocomposite synthesized via cost effective methods.
Qayyum A, Batool Z, Fatima M, Buzdar SA, Ullah H, Nazir A, Jabeen Q, Siddique S, Imran R. Qayyum A, et al. Sci Rep. 2022 Aug 22;12(1):14287. doi: 10.1038/s41598-022-17332-7. Sci Rep. 2022. PMID: 35995797 Free PMC article.
In addition, the in vivo toxicity of synthesized Bi(2)O(3)/CuO/GO nanocomposite is investigated on Swiss Albino mice at dose of 20 mg/kg by evaluating immune response, hematology and biochemistry at the time period of 2, 7, 14 and 30 days. ...The p value calculated by stat …
In addition, the in vivo toxicity of synthesized Bi(2)O(3)/CuO/GO nanocomposite is investigated on Swiss Albino mice at dose of 20 mg …
36 results